Brought to you by 
Alza, Bayer co-promote Ditropan, Cipro
05 Oct 2000
Executive Summary
In a deal industry analysts speculate has no revenue exchange, Alza will co-promote Bayer Corp.'s Cipro (ciprofloxacin)--a fluoroquinolone antibiotic for urinary tract infections, female acute cystitis, and chronic bacterial prostatitis--to urologists, obstetricians, and gynecologists. Bayer will co-promote Alza's Ditropan XL (extended-release oxybutynin) overactive bladder drug to urologists.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Product or Technology Swap
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Alza, Bayer co-promote Ditropan, Cipro
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice